Neonatal screening: new recommendations

Health Council of the Netherlands
Record ID 32015000615
English
Authors' recommendations: Shortly after birth, almost every baby in our country undergoes a heel prick test. At the moment, the blood thus acquired is tested for 17 diseases, for which early detection is important in order to prevent or limit health damage. The neonatal screening field is dynamic. Treatment options for some diseases have improved significantly in recent years, and there are also diseases that can be detected better than before. In addition, several social and ethical questions have arisen about the neonatal screening programme. Two issues are particularly salient: the exact goal of neonatal screening, and dealing with incidental findings, such as carrier status for diseases. Considering these scientific and social developments, the Minister of Health, Welfare and Sport decided to request advice from the Health Council of the Netherlands. Specifically, she also asked which diseases should be added to the neonatal screening programme. A specially appointed Committee drafted the requested advisory report.
Details
Project Status: Completed
Year Published: 2015
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Netherlands
MeSH Terms
  • Humans
  • Infant, Newborn
  • Mass Screening
  • Infant, Newborn, Diseases
  • Netherlands
  • Guidelines as Topic
Contact
Organisation Name: Health Council of the Netherlands Gezondheidsraad
Contact Address: Postbus 16052, 2500 BB Den Haag, The Netherlands. Tel: +31 70 340 7520;Fax: +31 70 340 7523
Contact Name: info@gr.nl
Contact Email: info@gr.nl
Copyright: Health Council of the Netherlands
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.